Categories Cancer

Global Castrate-resistant Prostate Cancer Market By Therapy, By Region, Industry Analysis and …

Global Castrate-resistant Prostate Cancer Market By Therapy, By Region, Industry Analysis and … New York, Feb. 10, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Castrate-resistant Prostate Cancer Market By Therapy, By Region, Industry Analysis and Forecast, 2020 – 2026” – https://www.reportlinker.com/p06021881/?utm_source=GNW The global market of CRPC is estimated to rise […]

Read More
Categories Cancer

Breakthroughs That Can Help Breast Cancer Patients Improve Quality Of Life

Breakthroughs That Can Help Breast Cancer Patients Improve Quality Of Life Oncologists are increasingly understanding that a one-size-fits-all approach is not the best way to treat breast cancer. Many factors play a role in selecting the best treatment path, including the disease stage, tumour biology and of course the patient’s preferences. Image: Shutterstock Another important […]

Read More
Categories Cancer

Study reveals why Black men with prostate cancer have greater survival benefits from …

Study reveals why Black men with prostate cancer have greater survival benefits from … Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment. A new Northwestern Medicine study discovered the reason appears to be an increase of a surprising type of immune cell in the tumor. The […]

Read More
Categories Uncategorized

Actinium Announces Participation in BIO CEO & Investor Digital Conference

Actinium Announces Participation in BIO CEO & Investor Digital Conference NEW YORK, Feb. 10, 2021 /PRNewswire/ — Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) (“Actinium” or the “Company”) today announced that management will participate in the BIO CEO & Investor conference, which is being held digitally February 16 – 18, 2021. Members of Actinium’s executive team […]

Read More
Categories Multiple Myeloma

FDA Clears Way for Clinical Trial of HDP-101

FDA Clears Way for Clinical Trial of HDP-101 Heidelberg Pharma has been cleared in the U.S. to begin a clinical trial testing its investigational therapy HDP-101 for the treatment of multiple myeloma. The U.S. Food and Drug Administration (FDA) allowed the start of a Phase 1/2a trial following the submission of an investigational new drug […]

Read More
Categories Multiple Myeloma

2018 Treatment Algorithm for Multiple Myeloma

2018 Treatment Algorithm for Multiple Myeloma Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions 2018 Treatment Algorithm for Multiple Myeloma Presented by S. Vincent Rajkumar, MD Friday, December 8, 2017 Atlanta, Georgia Friday Satellite Symposium preceding the 59th ASH Annual Meeting & Exposition. This activity is supported by educational grants from […]

Read More